Dr. Bharti Shetye, also known as Dr. Abby, CEO and Physician Owner of Dr. Abby’s Weight Management Clinic, recently joined Gayle Guyardo, host of the global health and ...

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

What happens when people quit weight loss drugs Some people may quit Mounjaro as their insurance no longer supports it or they may be experiencing some unpleasant side ... take GLP-1 drugs anymore.

Allison Debussy, an APRN with Baptist Health Weight Loss Center, shed some light on these increasingly popular ... like all medications, GLP-1 drugs come with potential side effects.

Americans spent an estimated $71.7 billion on GLP-1 drugs including Ozempic and Wegovy in 2023, a 500 percent increase from ...

Demand for GLP-1 drugs is causing spending on traditional ... with many citing uncomfortable side effects from the medications or concerns about medication safety. Patients can lose as much ...

As the chart below illustrates ... be driving the sell-off is the rise of generic GLP-1 drugs, which are not approved by the FDA. Despite their popularity, Lilly is competing with sellers of ...

Popular weight-loss and type 2 diabetes drugs such as Wegovy and Ozempic are typically taken as self-administered injections—a bearable albeit unpleasant jab to the abdomen or thigh. But drug ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Sarah Makowicki, 42, tried the other medications and said she suffered serious side effects. The graduate student and statehouse intern is working on a bill that would restore the full GLP-1 ...